This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2000;283:596.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Last June, a major finished product manufacturer of penicillin G (potassium and sodium) in the United States recalled its penicillin G injection products and ceased their distribution. (For details see http://www.fda.gov/medwatch/safety/1999/penici.htm.)

To remedy the resulting shortage, the FDA has identified Biochemie GmbH of Kundl, Austria, as a temporary alternative supplier of penicillin G sodium. The product is labeled and distributed by Geneva Pharmaceuticals Inc in Broomfield, Colo, which is operating under a drug shortage allocation program. Limited supplies are available through regular US wholesale suppliers. While the shortage lasts, physicians are advised to use, where possible, alternative approved therapies instead of penicillin G.

The contact for emergency allocations of penicillin G sodium is Jenny Whitehouse at Geneva Pharmaceuticals Inc, at (303) 438-4399 (telephone); (303) 727-4556 (fax); or jenny.whitehouse@gx.novartis.com (e-mail). An alternative source of penicillin G potassium in frozen bags is Baxter Corp (Web site, http://www.baxter.com). The FDA will . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gender Differences in Posttraumatic Stress Disorder After Motor Vehicle Accidents
Fullerton et al.
Am. J. Psychiatry 2001;158:1486-1491.
ABSTRACT | FULL TEXT